Drug pricing regime needs to be predictable,transparent:Sanofi

Government must not place the entire burden of access to healthcare on the pharmaceutical industry alone, Sanofi India has said responding to more medicines being put under price control. Speaking at the company’s annual general meeting held on April 29, the Sanofi India Managing Director Shailesh Ayyangar said any pricing regime must be predictable and transparent. In December 2015, the Ministry of Health and Family Welfare notified the National List of Essential Medicines, 2015 (NLEM) 2015, resulting in over 100 new molecules being added and 70 molecules being excluded from the earlier list of 2011, he added.